Kymera Therapeutics (KYMR) Stock Chart & Stock Price History $25.46 +0.03 (+0.12%) Closing price 04:00 PM EasternExtended Trading$25.48 +0.02 (+0.08%) As of 05:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Kymera Therapeutics Stock Price Performance 5 Day Performance+13.08%1 Month Performance-26.30%3 Month Performance-41.85%6 Month Performance-43.46%Year-To-Date Performance-37.04%1 Year Performance-26.34% Receive KYMR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kymera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address KYMR Stock Chart for Tuesday, April, 15, 2025 KYMR Chart by TradingViewRemove Ads Kymera Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/14/2025$24.12$25.43+5.43%$25.57$24.23700,472 shs$1.65 billion04/11/2025$22.40$24.12+7.68%$24.93$22.05938,673 shs$1.57 billion04/10/2025$23.95$22.40-6.47%$23.43$20.251.70 million shs$1.45 billion04/09/2025$21.05$23.95+13.78%$25.17$19.451.79 million shs$1.56 billion04/09/2025$21.05$23.95+13.78%$25.17$19.451.79 million shs$1.56 billion04/08/2025$22.01$21.05-4.36%$23.78$20.251.14 million shs$1.37 billion04/08/2025$22.01$21.05-4.36%$23.78$20.251.14 million shs$1.37 billion04/07/2025$22.07$22.01-0.27%$22.48$19.751.18 million shs$1.43 billion04/04/2025$23.69$22.07-6.84%$22.99$21.401.20 million shs$1.43 billion04/03/2025$26.36$23.69-10.13%$25.07$23.64709,266 shs$1.54 billion Get the Latest News and Ratings for KYMR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kymera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/02/2025$25.24$26.36+4.44%$26.79$24.43717,232 shs$1.71 billion04/01/2025$27.37$25.24-7.78%$27.37$24.361.43 million shs$1.64 billion03/31/2025$29.62$27.37-7.60%$28.75$26.991.00 million shs$1.78 billion03/28/2025$30.20$29.62-1.92%$30.42$29.34357,093 shs$1.92 billion03/27/2025$30.39$30.20-0.63%$30.89$30.00211,978 shs$1.96 billion03/26/2025$31.82$30.39-4.49%$31.83$29.83476,678 shs$1.97 billion03/25/2025$33.70$31.82-5.58%$34.10$31.53511,062 shs$2.07 billion03/24/2025$32.54$33.70+3.56%$35.28$32.88416,570 shs$2.19 billion03/21/2025$33.21$32.54-2.02%$33.90$32.08868,196 shs$2.11 billion03/20/2025$33.87$33.21-1.95%$34.71$32.98608,869 shs$2.16 billion03/19/2025$34.03$33.87-0.47%$34.75$32.75506,379 shs$2.20 billion03/18/2025$34.49$34.03-1.33%$34.41$33.15554,825 shs$2.21 billion03/17/2025$34.37$34.49+0.35%$34.71$33.37374,478 shs$2.24 billion03/14/2025$33.45$34.37+2.75%$34.99$33.61665,875 shs$2.23 billion Related Companies TGTX Stock Chart LEGN Stock Chart TLX Stock Chart SRPT Stock Chart BPMC Stock Chart AXSM Stock Chart NUVL Stock Chart ADMA Stock Chart KRYS Stock Chart GRFS Stock Chart Receive KYMR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kymera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KYMR) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kymera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kymera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
